home / stock / viri / viri news

VIRI News and Press, Virios Therapeutics Inc. From 07/17/23

Stock Information
Company Name: Virios Therapeutics Inc.
Stock Symbol: VIRI
Market: NASDAQ
Website: virios.com
Menu
VIRI VIRI Quote VIRI Short VIRI News VIRI Articles VIRI Message Board
Get VIRI Alerts

News, Short Squeeze, Breakout and More Instantly...
VIRI - Virios Therapeutics Announces Positive Data Demonstrating Improvement in Multiple Long-COVID Symptoms Following Treatment with a Combination of Valacyclovir and Celecoxib in an Exploratory, Open-Label, Proof of Concept Study

ATLANTA, July 17, 2023 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, including fibromyalgia (“FM”), ...
VIRI - CytoMed, Eloxx top healthcare gainers; Journey Medical, ADC Therapeutics among losers

2023-07-11 10:06:43 ET Gainers: CytoMed Therapeutics ( GDTC ) +128% . Eloxx Pharmaceuticals ( ELOX ) +29% . UpHealth ( UPH ) +13% . Virios Therapeutics ( VIRI ) +13% . Acumen Pharmaceuticals ( ABOS ) +9% . Losers: Jou...

VIRI - LUMN, OPEN and COHR are among consumer movers

2023-06-14 08:32:59 ET IO Biotech ( IOBT ) +33% Announces Achievement of Significant Phase 3 Clinical Trial Recruitment Milestone. WiSA Technologies ( WISA ) +36% . Inventiva ( IVA ) +35% announces positive topline results from the investigator-initia...

VIRI - CCL, S and LL are among pre market gainers

2023-06-12 08:29:19 ET Infobird ( IFBD ) +72% . Chinook Therapeutics ( KDNY ) +65% Novartis to acquire Chinook Therapeutics for $3.2B. Asset Entities  ( ASST ) +35% Develops AI Bot as Part of its AE360DDM Suite of Services on Discord in connection wi...
VIRI - Virios Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

ATLANTA, May 25, 2023 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a clinical‐stage biopharmaceutical company, today announced that it has regained compliance with the minimum bid price requirement for continued listing on The Nasdaq Capit...

VIRI - Virios Therapeutics Announces Submission of Final Toxicology Results to Support Proposed Phase 3 Program for Novel Therapy to Treat Fibromyalgia

ATLANTA, May 15, 2023 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, including fibromyalgia (“FM”), t...

VIRI - Virios Therapeutics GAAP EPS of -$0.08 beats by $0.12

2023-05-11 10:03:57 ET Virios Therapeutics press release ( NASDAQ: VIRI ): Q1 GAAP EPS of -$0.08 beats by $0.12 . As of March 31, 2023, Virios Therapeutics’ cash totaled $5.3 million. For further details see: Virios Therapeutics GAAP EPS of -$0.08 beat...
VIRI - Virios Therapeutics Announces First Quarter 2023 Financial Results

ATLANTA, May 11, 2023 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, including fibromyalgia (“FM”), t...

VIRI - Virios Therapeutics to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023

ATLANTA, Ga., May 04, 2023 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI ) (the “Company”), a development-stage biotechnology company focused on advancing novel, combination antiviral therapies to treat debilitating chronic diseases, including fibromyalgia ...

VIRI - Why Is TRACON Pharma (TCON) Stock Down 51% Today?

2023-04-25 09:11:29 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips TRACON Pharmaceuticals (NASDAQ: TCON ) stock is falling on Tuesday following an update on a legal battle with I-Mab (NASDAQ: IMAB ). The bad news for TCO...
Previous 10 Next 10